Vector integration and fate in the hemophilia dog liver multiple years after AAV-FVIII gene transfer

Abstract excerpt

ABSTRACT: Gene therapy using adeno-associated virus (AAV) vectors is a promising approach for the treatment of monogenic disorders. Long-term multiyear transgene expression has been demonstrated in animal models and clinical studies. Nevertheless, uncertainties remain concerning the nature of AAV vector persistence and whether there is a potential for genotoxicity. Here, we describe the mechanisms of AAV vector...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hemophilia Treatment and Research
• Share to Parvovirus B19 Infection Studies
• Share to Virus-based gene therapy research